Cargando…

Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors

OBJECTIVE: Coronavirus disease 2019 is a disease caused by severe acute respiratory syndrome coronavirus 2, a novel type of coronavirus, which causes pneumonia in some hosts. No specific scoring method exists for mortality evaluation in novel coronavirus pneumonia. The aim of this study was to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Ensarioğlu, Kerem, Erdöl, Ayşe Kevser, Kurt, Bahar, Şencan, İrfan, Hikmet Fırat, İbrahim, Bağnu Yüceege, Melike, Duru Akçalı, Serap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Thoracic Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524495/
https://www.ncbi.nlm.nih.gov/pubmed/35943073
http://dx.doi.org/10.5152/TurkThoracJ.2022.21029
_version_ 1784800519033716736
author Ensarioğlu, Kerem
Erdöl, Ayşe Kevser
Kurt, Bahar
Şencan, İrfan
Hikmet Fırat, İbrahim
Bağnu Yüceege, Melike
Duru Akçalı, Serap
author_facet Ensarioğlu, Kerem
Erdöl, Ayşe Kevser
Kurt, Bahar
Şencan, İrfan
Hikmet Fırat, İbrahim
Bağnu Yüceege, Melike
Duru Akçalı, Serap
author_sort Ensarioğlu, Kerem
collection PubMed
description OBJECTIVE: Coronavirus disease 2019 is a disease caused by severe acute respiratory syndrome coronavirus 2, a novel type of coronavirus, which causes pneumonia in some hosts. No specific scoring method exists for mortality evaluation in novel coronavirus pneumonia. The aim of this study was to investigate factors affecting coronavirus disease 2019 mortality and comparison of pneumonia scoring systems, pneumonia severity index, CURB-65, and MuLBSTA. MATERIAL AND METHODS: In this single-center clinical study, 151 patients who had been diagnosed with coronavirus disease 2019 infection and pneumonia between March 11 and May 31, 2020, were evaluated retrospectively. Correlation between patients’ symptoms, comorbidities, drugs in use, radiological findings, and mortality was investigated. Parameters were also evaluated regarding their contribution to additional treatment requirements and days of fever response. RESULTS: A correlation between mortality and higher scores of pneumonia severity index, CURB-65, and MuLBSTA was found. When parameters were investigated separately, elevated glucose and urea levels, presence of diabetes, renal failure, hypertension, chronic obstructive pulmonary disease, cerebrovascular events and known malignancies, lymphocyte count, smoking history, radiological findings, and age correlated with mortality. In addition to these parameters, elevated calcium, potassium, brain natriuretic peptide, troponin, d-dimer, C-reactive protein, HC03, and lactate dehydrogenase levels were found significant regarding mortality. These parameters were not found statistically relevant regarding additional treatment requirement, fever response day, and total treatment duration. Conclusion: A modified version of present pneumonia scoring systems will be required to rigorously evaluate the severity of a patient’s condition. A new scoring system that uses components of the present ones may prove useful and with further studies, a similar follow-up algorithm may be created.
format Online
Article
Text
id pubmed-9524495
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-95244952022-10-13 Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors Ensarioğlu, Kerem Erdöl, Ayşe Kevser Kurt, Bahar Şencan, İrfan Hikmet Fırat, İbrahim Bağnu Yüceege, Melike Duru Akçalı, Serap Turk Thorac J Original Article OBJECTIVE: Coronavirus disease 2019 is a disease caused by severe acute respiratory syndrome coronavirus 2, a novel type of coronavirus, which causes pneumonia in some hosts. No specific scoring method exists for mortality evaluation in novel coronavirus pneumonia. The aim of this study was to investigate factors affecting coronavirus disease 2019 mortality and comparison of pneumonia scoring systems, pneumonia severity index, CURB-65, and MuLBSTA. MATERIAL AND METHODS: In this single-center clinical study, 151 patients who had been diagnosed with coronavirus disease 2019 infection and pneumonia between March 11 and May 31, 2020, were evaluated retrospectively. Correlation between patients’ symptoms, comorbidities, drugs in use, radiological findings, and mortality was investigated. Parameters were also evaluated regarding their contribution to additional treatment requirements and days of fever response. RESULTS: A correlation between mortality and higher scores of pneumonia severity index, CURB-65, and MuLBSTA was found. When parameters were investigated separately, elevated glucose and urea levels, presence of diabetes, renal failure, hypertension, chronic obstructive pulmonary disease, cerebrovascular events and known malignancies, lymphocyte count, smoking history, radiological findings, and age correlated with mortality. In addition to these parameters, elevated calcium, potassium, brain natriuretic peptide, troponin, d-dimer, C-reactive protein, HC03, and lactate dehydrogenase levels were found significant regarding mortality. These parameters were not found statistically relevant regarding additional treatment requirement, fever response day, and total treatment duration. Conclusion: A modified version of present pneumonia scoring systems will be required to rigorously evaluate the severity of a patient’s condition. A new scoring system that uses components of the present ones may prove useful and with further studies, a similar follow-up algorithm may be created. Turkish Thoracic Society 2022-09-01 /pmc/articles/PMC9524495/ /pubmed/35943073 http://dx.doi.org/10.5152/TurkThoracJ.2022.21029 Text en Turkish Thoracic Society https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Ensarioğlu, Kerem
Erdöl, Ayşe Kevser
Kurt, Bahar
Şencan, İrfan
Hikmet Fırat, İbrahim
Bağnu Yüceege, Melike
Duru Akçalı, Serap
Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title_full Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title_fullStr Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title_full_unstemmed Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title_short Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors
title_sort coronavirus disease 2019 pneumonia scoring system comparison and risk factors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524495/
https://www.ncbi.nlm.nih.gov/pubmed/35943073
http://dx.doi.org/10.5152/TurkThoracJ.2022.21029
work_keys_str_mv AT ensarioglukerem coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT erdolaysekevser coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT kurtbahar coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT sencanirfan coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT hikmetfıratibrahim coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT bagnuyuceegemelike coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors
AT duruakcalıserap coronavirusdisease2019pneumoniascoringsystemcomparisonandriskfactors